BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 32984855)

  • 1. Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters.
    Lee AC; Zhang AJ; Chan JF; Li C; Fan Z; Liu F; Chen Y; Liang R; Sridhar S; Cai JP; Poon VK; Chan CC; To KK; Yuan S; Zhou J; Chu H; Yuen KY
    Cell Rep Med; 2020 Oct; 1(7):100121. PubMed ID: 32984855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
    Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
    mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
    Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persimmon-derived tannin has antiviral effects and reduces the severity of infection and transmission of SARS-CoV-2 in a Syrian hamster model.
    Furukawa R; Kitabatake M; Ouji-Sageshima N; Suzuki Y; Nakano A; Matsumura Y; Nakano R; Kasahara K; Kubo K; Kayano SI; Yano H; Ito T
    Sci Rep; 2021 Dec; 11(1):23695. PubMed ID: 34880383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
    Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
    Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
    O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A
    EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling.
    Bednash JS; Kagan VE; Englert JA; Farkas D; Tyurina YY; Tyurin VA; Samovich SN; Farkas L; Elhance A; Johns F; Lee H; Cheng L; Majumdar A; Jones D; Mejia OR; Ruane-Foster M; Londino JD; Mallampalli RK; Robinson RT
    Transl Res; 2022 Feb; 240():1-16. PubMed ID: 34740873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Hamster Natural Transmission Model of SARS-CoV-2 Infection.
    Dowall S; Salguero FJ; Wiblin N; Fotheringham S; Hatch G; Parks S; Gowan K; Harris D; Carnell O; Fell R; Watson R; Graham V; Gooch K; Hall Y; Mizen S; Hewson R
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.
    Sia SF; Yan LM; Chin AWH; Fung K; Choy KT; Wong AYL; Kaewpreedee P; Perera RAPM; Poon LLM; Nicholls JM; Peiris M; Yen HL
    Nature; 2020 Jul; 583(7818):834-838. PubMed ID: 32408338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical symptoms and signs in hamsters during experimental infection with the SARS-CoV-2 virus (Coronaviridae:
    Tuyskanova MS; Zhugunissov KD; Ozaslan M; Myrzakhmetova BS; Kutumbetov LB
    Vopr Virusol; 2023 Dec; 68(6):513-525. PubMed ID: 38156567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum.
    Handley A; Ryan KA; Davies ER; Bewley KR; Carnell OT; Challis A; Coombes NS; Fotheringham SA; Gooch KE; Charlton M; Harris DJ; Kennard C; Ngabo D; Weldon TM; Salguero FJ; Funnell SGP; Hall Y
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression and Resolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Golden Syrian Hamsters.
    Mulka KR; Beck SE; Solis CV; Johanson AL; Queen SE; McCarron ME; Richardson MR; Zhou R; Marinho P; Jedlicka A; Guerrero-Martin S; Shirk EN; Braxton AM; Brockhurst J; Creisher PS; Dhakal S; Brayton CF; Veenhuis RT; Metcalf Pate KA; Karakousis PC; Zahnow CA; Klein SL; Jain SK; Tarwater PM; Pekosz AS; Villano JS; Mankowski JL;
    Am J Pathol; 2022 Feb; 192(2):195-207. PubMed ID: 34767812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.
    Rosenke K; Meade-White K; Letko M; Clancy C; Hansen F; Liu Y; Okumura A; Tang-Huau TL; Li R; Saturday G; Feldmann F; Scott D; Wang Z; Munster V; Jarvis MA; Feldmann H
    Emerg Microbes Infect; 2020 Dec; 9(1):2673-2684. PubMed ID: 33251966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models.
    Choudhary S; Kanevsky I; Yildiz S; Sellers RS; Swanson KA; Franks T; Rathnasinghe R; Munoz-Moreno R; Jangra S; Gonzalez O; Meade P; Coskran T; Qian J; Lanz TA; Johnson JG; Tierney CA; Smith JD; Tompkins K; Illenberger A; Corts P; Ciolino T; Dormitzer PR; Dick EJ; Shivanna V; Hall-Ursone S; Cole J; Kaushal D; Fontenot JA; Martinez-Romero C; McMahon M; Krammer F; Schotsaert M; García-Sastre A
    Toxicol Pathol; 2022 Apr; 50(3):280-293. PubMed ID: 35128980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in SARS-CoV-2 Virus Infectivity in Human and Hamster Feces.
    Wurtzer S; Lacote S; Murri S; Marianneau P; Monchatre-Leroy E; Boni M; Ferraris O; Maday Y; Kébé O; Dia N; Peyrefitte C; Sokol H; Obepine Consortium ; Moulin L; Maréchal V
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and validation of an exposure system for efficient inter-animal SARS-CoV-2 airborne transmission in Syrian hamsters.
    Kuehl PJ; Dearing J; Werts A; Cox J; Irshad H; Barrett EG; Tucker SN; Langel SN
    Microbiol Spectr; 2023 Dec; 11(6):e0471722. PubMed ID: 37882564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters.
    Port JR; Yinda CK; Owusu IO; Holbrook M; Fischer R; Bushmaker T; Avanzato VA; Schulz JE; Martens C; van Doremalen N; Clancy CS; Munster VJ
    Nat Commun; 2021 Aug; 12(1):4985. PubMed ID: 34404778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
    Suresh V; Mohanty V; Avula K; Ghosh A; Singh B; Reddy RK; Parida D; Suryawanshi AR; Raghav SK; Chattopadhyay S; Prasad P; Swain RK; Dash R; Parida A; Syed GH; Senapati S
    FASEB J; 2021 Jul; 35(7):e21713. PubMed ID: 34105201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.
    Chan JF; Zhang AJ; Yuan S; Poon VK; Chan CC; Lee AC; Chan WM; Fan Z; Tsoi HW; Wen L; Liang R; Cao J; Chen Y; Tang K; Luo C; Cai JP; Kok KH; Chu H; Chan KH; Sridhar S; Chen Z; Chen H; To KK; Yuen KY
    Clin Infect Dis; 2020 Dec; 71(9):2428-2446. PubMed ID: 32215622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific features of the pathology of the respiratory system in SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus: Sarbecovirus) infected Syrian hamsters (Mesocricetus auratus)].
    Chepur SV; Alekseeva II; Vladimirova OO; Myasnikov VA; Tyunin MA; Ilinskii NS; Nikishin AS; Shevchenko VA; Smirnova AV
    Vopr Virusol; 2022 Jan; 66(6):442-451. PubMed ID: 35019251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.